Trials / Active Not Recruiting
Active Not RecruitingNCT06301997
A Herbal Compound for Psoriasis
Evaluation of Therapeutic Effects of ZAX.1400.P03 a Herbal Compound on Clinical Signs of Skin in Psoriasis Patients
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 104 (actual)
- Sponsor
- Fasa University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this interventional clinical trial study is to compare ZAX.1400.P03 and placebo in Psoriasis patients. The main question it aims to answer is: • Can treatment with ZAX.1400.P03 for 3 weeks improve clinical signs of skin in psoriasis patients? Participants will be divided into two groups of 52 people. One group will use ZAX.1400.P03 topically twice daily for 3 weeks and the other group will use placebo topically twice daily for 3 weeks. Researchers will compare treatment and placebo groups to see if there is any improvement in the clinical signs of skin caused by psoriasis after treatment with ZAX.1400.P03 for 3 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ZAX.1400.P03 | ZAX.1400.P03, applied twice daily for 3 weeks after enrolment |
| DRUG | Placebo | Placebo, applied twice daily for 3 weeks after enrolment |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2025-06-30
- Completion
- 2025-07-30
- First posted
- 2024-03-08
- Last updated
- 2025-03-12
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT06301997. Inclusion in this directory is not an endorsement.